FidoCure®

FidoCure® YC Application

Winter 2018Active

FidoCure® went through Y Combinator in the Winter 2018 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch
Winter 2018
Industry
HealthcareHealthcare Services
Team size
14
Status
Active
Launched
2018

Founders

  • christina lopes
    christina lopesFounder

What FidoCure® does

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US. Together, we can combat canine cancer!

FidoCure®'s YC application, reconstructed

Y Combinator application

FidoCure®, Winter 2018 batch. The real form questions, answered from public data.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

FidoCure®

Describe what your company does in 50 characters or less.

Precision medicine for canine cancer

What is your company going to make? Please describe your product and what it does or will do.

We built a platform that offers genetic sequencing and targeted therapies for dogs with cancer. Veterinarians use our service to identify the genetic mutations driving each dog's cancer and get tailored treatment options. This improves treatment effectiveness in canine oncology where options have been limited.

Where do you live now, and where would the company be based after YC?

We live in Palo Alto, CA and have a remote team. Post-YC, the company will continue to be based in Palo Alto with distributed staff.

Explain your decision regarding location.

Palo Alto is fertile ground for healthcare tech talent and close to experts in precision medicine. Being remote lets us tap talent nationwide while maintaining headquarters in a key innovation hub.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

Frequently Asked Questions

Is this the real FidoCure® YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from FidoCure®'s public data (launch notes, founder backgrounds, product description). It shows how a company like FidoCure® would present itself to YC, not the text they submitted.

What YC batch was FidoCure® in?

FidoCure® was part of the Y Combinator Winter 2018 batch.

Who founded FidoCure®?

FidoCure® was founded by christina lopes.

What does FidoCure® do?

FidoCure® is the leader in Precision Medicine for Canine Oncology.

How do I read the full reconstructed application?

Create a free Round Funded account. The full 26-answer version of FidoCure®'s application, and every other YC batch, is in YC Insights.

More YC startups like FidoCure®